• share
• favorite_border

Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University today named Judy Aschner, M.D., chair of the pediatrics department at The Children’s Hospital at Montefiore and professor and university chair of pediatrics at Einstein. Aschner joins from Monroe Carell Jr. Children’s Hospital at Vanderbilt University School of Medicine, where she has served as director of neonatology and the Julia Carell Stadler professor of pediatrics. She will assume her new position in April 2013.

• share
• favorite_border

A study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that body mass index (BMI)—the most commonly used weight-for-height formula for estimating fatness—may not be the best measure for estimating disease risk, and particularly the risk of certain types of cancer. The study was published today in the online edition of the American Journal of Epidemiology.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.

• share
• favorite_border

A team of researchers including Arturo Casadevall, M.D., Ph.D., of Albert Einstein College of Medicine, has found that misconduct is responsible for two-thirds of all scientific paper retractions.

• share
• favorite_border

The promise of stem cells seems limitless. If they can be coaxed into rebuilding organs, repairing damaged spinal cords and restoring ravaged immune systems, these malleable cells would revolutionize medical treatment. But stem cell research is still in its infancy, as scientists seek to better understand the role of these cells in normal human development and disease.

• share
• favorite_border

A team of researchers, led by Martha Grayson, M.D., at Albert Einstein College of Medicine, have found that debt and income expectations deter med school students from entering into primary care.

• share
• favorite_border

Why does cancer arise in certain parts of the body and not others? How exactly does it spread? These are critical questions that cannot be answered clearly despite decades of cancer research. Answers to complex but central questions about cancer have long stymied efforts to “win the war” on the disease.

• share
• favorite_border

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded nearly $11 million to Albert Einstein College of Medicine of Yeshiva University to carry out a five-year multi-institutional study of hemoglobin toxicity that may complicate blood transfusions and reduce the effectiveness of blood substitutes. The long-term goals include making blood transfusions safer and more effective and better matching patients with the transfusion strategy best suited to them

• share
• favorite_border

Social media is increasingly popular but engaging in its proper use can prove confusing and challenging – especially in the medical and healthcare arenas. Albert Einstein College of Medicine (http://www.einstein.yu.edu/) of Yeshiva University has been awarded a two-year grant to educate faculty members and medical students on using social media appropriately and effectively. Einstein is one of four medical schools in the United States to be selected for the 2012 Education and Training to Professionalism Initiative by the Institute on Medicine as a Profession (IMAP) and the Josiah Macy Jr. Foundation.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a new “first response” mechanism that the immune system uses to respond to infection. The findings challenge the current understanding of immunity and could lead to new strategies for boosting effectiveness of all vaccines. The study, conducted in mice, published online today in the journal Immunity.

• share
• favorite_border

Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.

• share
• favorite_border

A new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. The findings support the historical record of Middle Eastern Jews settling in North Africa during Classical Antiquity, proselytizing and marrying local populations, and, in the process, forming distinct populations that stayed largely intact for more than 2,000 years. The study, led by researchers at Albert Einstein College of Medicine of Yeshiva University, was published online today in the Proceedings of the National Academy of Sciences.

• share
• favorite_border

In a study published online in Science, researchers at Albert Einstein College of Medicine of Yeshiva University have determined the complete wiring diagram for the part of the nervous system controlling mating in the male roundworm Caenorhabditis elegans, an animal model intensively studied by scientists worldwide.

• share
• favorite_border

Compared to the general population, HIV-positive women have a high risk of cervical cancer and thus are advised to undergo more frequent screening tests. This creates a burden for HIV-positive patients and the health care system, leading to frequent biopsies, which often do not reveal clinically relevant disease.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine (http://www.einstein.yu.edu/) of Yeshiva University have uncovered one of the mechanisms by which aging may compromise the ability of the immune system to fight infections and respond to vaccines. The study, conducted in aging mice, shows that administering antioxidants may help reverse this loss of immune function. The findings were published online this month in the journal Cell Reports.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center found that people with a form of mild cognitive impairment (MCI), a risk factor for developing Alzheimer’s disease, have twice the risk of dying compared with cognitively normal people. Those with dementia have three times the risk. The findings are being presented at the Alzheimer’s Association International Conference in Vancouver this week.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine of Yeshiva University a five-year, $4.8 million grant to study the molecular mechanism that allows the Ebola virus to cause infection and spread in animals.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS).

• share
• favorite_border

Patients vary widely in their response to concussion, but scientists haven’t understood why. Now, using a new technique for analyzing data from brain imaging studies, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found that concussion victims have unique spatial patterns of brain abnormalities that change over time.

• share
• favorite_border

The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology of Yeshiva University have found that personality traits like being extroverted, enjoying laughter and staying engaged may also be part of the longevity genes mix that allows some people to reach age 100 and beyond. The findings published online May 21 in the journal Aging.

• share
• favorite_border

U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg, M.D., will deliver the keynote address at the 2012 commencement ceremony for Albert Einstein College of Medicine of Yeshiva University. Einstein’s 54th graduation will take place at Lincoln Center’s Avery Fisher Hall Wednesday, May 30 at 6:30 p.m.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive tissues and fuels the development of endometrial and breast cancers. The molecule, discovered in animal studies, could lead to new therapies for preventing and treating estrogen-related diseases in humans. The findings were published online April 26 in the PNAS Plus.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with Nurses’ Health Study investigators have shown that levels of certain related proteins found in blood are associated with a greatly reduced risk for developing type 2 diabetes up to a decade or more later. The findings, published today in the online edition of Diabetes, could open a new front in the war against diabetes.

• share
• favorite_border

Meredith Hawkins, M.D., professor of medicine and director of the Global Diabetes Initiative at Albert Einstein College of Medicine of Yeshiva University, will receive the American Federation for Medical Research’s (AFMR) highest honor for medical research, the Outstanding Investigator Award. The prestigious prize is given annually to one exceptional investigator aged 45 or younger for excellence in biomedical research.

• share
• favorite_border

Three leading cancer researchers at Albert Einstein College of Medicine of Yeshiva University have been selected to chair symposia at this year’s annual meeting of the American Association for Cancer Research, which will be held in Chicago from March 31 to April 4.

• share
• favorite_border

Members of Albert Einstein College of Medicine of Yeshiva University’s graduating class celebrated another strong year for residency placements in competitive specialties and prestigious programs at this year’s Match Day. Representing the culmination of their medical school education, Match Day marked the transition of Einstein’s class of 2012 into the post-graduate phase of their training – when they will practice medicine in a clinical setting under the supervision of fully licensed physicians.

• share
• favorite_border

Albert Einstein College of Medicine of Yeshiva University has earned an “A,” the top mark, for its conflict-of-interest policies from the American Medical Student Association (AMSA), the oldest and largest independent association of physicians-in-training in the United States.

• share
• favorite_border

A new study by researchers at Albert Einstein College of Medicine found that young children with sleep-disordered breathing are prone to developing behavioral difficulties such as hyperactivity and aggressiveness, as well as emotional symptoms and difficulty with peer relationships.

• share
• favorite_border

In a surprising finding with significant implications for older women, researchers at Albert Einstein College of Medicine of Yeshiva University and NYU School of Medicine have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women – more of a risk factor than elevated levels of total cholesterol or of low-density lipoprotein (LDL) cholesterol (known as “bad” cholesterol). The study appears online today in Stroke.

• share
• favorite_border

Communications and marketing strategist Paul Moniz has been named managing director of communications and marketing at Albert Einstein College of Medicine of Yeshiva University after a successful three-and-a-half-year run as a director in the College of Medicine’s Philip and Rita Rosen Department of Communications and Public Affairs. Mr. Moniz is a seasoned communications professional and an award-winning former broadcast journalist with 20 years of public relations and journalism experience.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have found a biomarker in head and neck cancers that can predict whether a patient’s tumor will be life threatening. The biomarker is considered particularly promising because it can detect the level of risk immediately following diagnosis. This discovery could become a component of a new test to guide how aggressively those with head and neck tumors should be treated. The findings were published online January 9 in the American Journal of Pathology.

• share
• favorite_border

What is it like to be a practicing physician in today’s world of breakthrough technologies, expanding therapeutic options, insurance challenges, health policy debates and increasingly savvy e-patients? Faculty members at Albert Einstein College of Medicine of Yeshiva University will provide a rare window into the lives of doctors navigating this evolving landscape with “The Doctor’s Tablet,” a new blog launched today on Einstein’s website.

• share
• favorite_border

To address the prospects for personalized medicine in diabetes, investigators from Albert Einstein College of Medicine have surveyed the field for existing research and published their findings in the January issue of Health Affairs. The authors are Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean and former director of the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH, and Meredith Hawkins, M.D., director of Einstein’s Global Diabetes Initiative.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered the first known mechanism by which cells control the survival of messenger RNA (mRNA)—arguably biology’s most important molecule. The findings pertain to mRNAs that help regulate cell division and could therefore have implications for reversing cancer’s out-of-control cell division. The research is described in today’s online edition of the journal Cell.

• share
• favorite_border

New York City Council Member James Vacca, along with administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University, celebrated the re-launch of Einstein’s Gruss Magnetic Resonance Research Center.

• share
• favorite_border

An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans – by literally starving the parasites to death. The study, published in the November 11, 2011 issue of PLoS ONE, was led by senior author Vern Schramm, Ph.D., professor and Ruth Merns Chair in Biochemistry at Einstein.

• share
• favorite_border

In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). One of only 25 such federally-funded centers in the country, the Einstein-Montefiore site was created in partnership with Einstein affiliates Beth Israel Medical Center in Manhattan and the North Shore-Long Island Jewish Health System. The NeuroNEXT network and its centers were established with grants from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.

• share
• favorite_border

Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University. The findings, observed in nearly 5,000 postmenopausal women, appear in the November 29 online edition of the British Journal of Cancer.

• share
• favorite_border

Using advanced imaging techniques and cognitive tests, researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have shown that repeatedly heading a soccer ball increases the risk for brain injury.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that cancer cells tap into a natural recycling system to obtain the energy they need to keep dividing. In a study with potential implications for cancer treatments, Einstein researchers used genetic manipulation to turn off this recycling system within the walls of cells and stop both tumor growth and metastasis (cancer spread). The findings were published in today’s online edition of Science Translational Medicine.

• share
• favorite_border

New York State Senator Jeffrey D. Klein joined administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University last Friday to officially open their new Cognitive Neurophysiology Laboratory. Several pieces of high-tech diagnostic and monitoring equipment, including advanced electroencephalogram (EEG) systems, stimulus delivery equipment and specialized video recording devices, were purchased through a $1 million capital grant that Senator Klein secured for Einstein in the 2009-2010 budget cycle.

• share
• favorite_border

Researchers at the Albert Einstein College of Medicine of Yeshiva University have uncovered a mechanism that governs how cells become specialized during development. Their findings could have implications for human health and disease and appear in the November 10 online edition of the journal Cell.

• share
• favorite_border

Researchers at Albert Einstein College of Medicine of Yeshiva University have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans. The findings, published today in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes.

• share
• favorite_border

The National Cancer Institute (NCI) has awarded Albert Einstein College of Medicine of Yeshiva University two grants totaling $8 million to study the microenvironments that drive the spread of cancer from the primary tumor to other parts of the body in the process known as metastasis.

• share
• favorite_border

A panel of prominent medical school deans from across the country convened yesterday in New York City to discuss the future of annual medical school rankings issued by U.S. News & World Report, which are now celebrating their 20th anniversary.

• share
• favorite_border

Nir Barzilai, M.D., director of the Institute for Aging Research at Albert Einstein College of Medicine of Yeshiva University, will help lead a newly formed centenarian consortium for the Archon Genomics X PRIZE presented by Medco. The $10 million dollar incentivized prize competition, which was announced today, challenges teams of scientists and entrepreneurs to sequence the complete genomes of 100 healthy centenarians in 30 days. Intended to help usher in an era of personalized medicine and learn from the genetic advantages of the exceptionally long-lived, the competition tasks teams with delivering medical quality genome sequencing results for $1,000 per centenarian.

• share
• favorite_border

Shinya Yamanaka, M.D., Ph.D., the internationally renowned scientist known for his pioneering work generating the first induced pluripotent stem cells (iPS cells), delivered the 2011 Lasker Lecture at Albert Einstein College of Medicine of Yeshiva University today. A standing-room-only crowd was on-hand for his presentation covering his initial groundbreaking research with iPS cells and his ongoing research in the field.

• share
• favorite_border

The Eunice Kennedy Shriver National Institute for Child Health and Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University $5.7 million to fund the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC). The grant supports Einstein’s ongoing efforts to improve the lives of children with intellectual and developmental disabilities (IDD) through combined basic science research and clinical practice.

• share
• favorite_border

The Eunice Kennedy Shriver National Institute of Child Health & Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University and collaborators at the Children’s Hospital of Philadelphia a five-year, $6.7 million grant to study the genetics of both rare and common congenital heart abnormalities known as conotruncal defects.